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ntroduction: Although the process of learning robotic surgery for rectal cancer is associated with a pro-
longed operating time and higher complication rates, its impact on histopathologic outcomes is unknown.
The aim of this meta-analysis was to evaluate the impact of the learning curve in robotic surgery for rectal
cancer on histopathologic outcomes.
Methods: The PubMed, EMBASE, Cochrane Library, MEDLINE via Ovid, CINAHL, and Web of Science
databases were systematically searched. The inclusion criterion was any clinical study comparing the
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At the turn of this century, the U.S.
Food and Drug Administration (FDA)
approved a robotic surgical system
(RSS), which has since been used in
thousands of operations.1 However,
questions have arisen in the literature
about patient safety and the appropriate
utilization of RSS.2 In fact, a sudden
increase in RSS-related adverse events
was reported to the FDA’s database
between 2012 and 2013.3 In 2013, the
Emergency Care Research Institute
included RSSs among the top 10 health
technology hazards, blaming insufficient
training.4 In addition to training consid-
erations, a small-sample FDA survey
reminded everyone of the learning
curve associated with RSSs. In fact, all
participating surgeons who were expe-
rienced with RSSs confirmed that expe-
rience with several cases was required
to achieve competence.5 In the specific
case of rectal cancer, attempts have been
made to structure training 6 as well as to
define the learning curve 7 in robotic
rectal cancer surgery. The few reports
that have analyzed the learning curve in
robotic proctectomy for cancer have
only studied operating time. According-
ly, it has been suggested that the learn-
ing curve should include 20 to 23 cases
for surgeons with previous experience
in conventional surgery.8,9 However, a
recent retrospective study suggested
that skills acquired in laparoscopic rectal
cancer surgery might have a beneficial
impact on the learning curve in robotic
rectal cancer surgery.10 Moreover, a
recent study found no association
between prolonged operating time and
morbidity rates.11 Histopathology,
rather than surrogate metrics, should
guide our understanding of whether
RSS may be in the best interest of
patients with rectal cancer. It has been
suggested that a potential benefit of
robotic proctectomy may be the
achievement of high rates of uninvolved
circumferential resection margin
(CRM), thanks to the ability of RSS
wristed instruments to overcome the
fulcrum effect created by the trocars
and the confined space of the pelvis.12
In this study, we performed a meta-
analysis to evaluate the impact of the
learning curve in robotic surgery for
rectal cancer on histopathologic out-
comes.
MATERIALS AND METHODS
This systematic review was per-
formed according to the Cochrane
Handbook for Systematic Reviews of
Interventions13 and follows the Pre-
ferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA)
and Meta-analysis Of Observational
Studies in Epidemiology (MOOSE)
guidelines.14,15 The protocol of this sys-
tematic review was developed a priori
and registered in PROSPERO, the
international prospective register of sys-
tematic reviews (CRD42018086633).
The literature search, screening of full-
text articles, inclusion and exclusion of
screened records, quality assessment,
data extraction and analysis, followed by
critical appraisal, were performed by
two independent researchers (MG and
KY). Any disagreements during this
process were discussed and resolved by
the senior authors. The research ques-
tion was formulated within the PICOTS
framework as follows:
(P) Population: Adults older than 18
years old
(I) Intervention: Robotic surgery for
rectal cancer during a surgeon’s
learning curve (LC)
(C) Comparator intervention: Robotic
surgery for rectal cancer after a sur-
geon has achieved competence (C)
(O) Outcomes: Pathologic and clinical
outcomes.
(T) Time: Short-term
(S) Setting: In- and outpatient
Eligibility criteria, Definitions
and Endpoints
The inclusion criterion for this sys-
tematic review was all clinical studies
that compared the outcomes of robotic
surgery for rectal cancer between dif-
ferent phases of the learning curve.
Exclusion criteria were any studies
involving the same subjects, technical
notes and summary design studies, and
studies that compared any of the inter-
ventions of interest to an intervention
irrelevant to this study, such as laparo-
scopic surgery for rectal cancer. 
The learning curve was defined as
any phase of the learning process pre-
ceding competence. The learning curve
could have two or more phases, such as
the initial learning phase and plateau
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INTRODUCTION 
MATERIALS A  METHODS
outcomes of robotic surgery for rectal cancer between different phases of the learning curve (LC) including
competence (C). The primary endpoint was the circumferential resection margin (CRM) involvement rate
defined as CRM ≤1 mm. The Mantel-Haenszel method with odds ratios with 95% confidence intervals (OR
(95%CI)) was used for dichotomous variables. 
Results: Ten studies including a total of 907 patients (521 LC and 386 C) were selected. Nine studies were
found to have a low risk of bias, and one had a moderate risk of bias. The CRM involvement rate was 2.9%
(13/441) for learning curve vs. 4.6% (13/284) for competence. This difference was not significant (OR (95%CI)
= 0.70 (0.30, 1.60); p=0.39; I2=0%). 
Conclusion: A surgeon’s learning curve seems to have no impact on CRM involvement rates compared to
surgeon competence in robotic surgery for rectal cancer. 
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phase. Circumferential resection margin
was determined microscopically and
expressed in mm. CRM was considered
to be involved if it was ≤1 mm. Quality
of total mesorectal excision (TME) was
assessed macroscopically by pathologists
and based on the number and size of
defects in the mesorectal fascia. Surgical
site infections (SSI) were defined
according to the Centers for Disease
Control (CDC) National Nosocomial
Infections Surveillance System.16 Anas-
tomotic leak was defined as clinical fea-
tures of peritoneal irritation with bowel
content, direct visualization of bowel
content in draining tubes, and/or radio-
logical extravasation of intraluminal
contrast through an anastomotic defect. 
The primary endpoint of this sys-
tematic review was the CRM involve-
ment rate.
Secondary endpoints were
Pathologic endpoints: Number of
lymph nodes harvested, distal mar-
gin, CRM in mm, and TME quality.
Clinical endpoints: Intraoperative
(operating time, docking time, sur-
geon console time, conversion rate,
estimated blood loss) and postopera-
tive (postoperative complication rate,
anastomotic leak rate, time to first
flatus, time to soft diet resumption,
length of hospital stay, and readmis-
sion rate).
Search strategy and study
selection
The PubMed, EMBASE, Cochrane
Library, MEDLINE via Ovid, CINAHL,
and Web of Science databases were sys-
tematically searched using the following
MeSH terms: ‘robotic’, ‘rectal cancer’,
and ‘learning curve’ combined with the
Boolean operator ‘AND’ and all syn-
onyms combined with the Boolean
operator ‘OR’. In addition, clinicaltri-
als.gov was searched for any ongoing
studies. Relevant articles were identi-
fied, and the results of the search were
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Figure 1. PRISMA flow diagram.
Supplement 1. 
Search strategy. PubMed
("robotics"[MeSH Terms] OR "robotics"[All Fields] OR "robotic"[All Fields]) AND ("rectal neoplasms"[MeSH Terms] OR ("rec-
tal"[All Fields] AND "neoplasms"[All Fields]) OR "rectal neoplasms"[All Fields] OR ("rectal"[All Fields] AND "cancer"[All
Fields]) OR "rectal cancer"[All Fields]) AND ("learning curve"[MeSH Terms] OR ("learning"[All Fields] AND "curve"[All
Fields]) OR "learning curve"[All Fields])
Records found: 77
- 142 -
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screened through the title, abstract
and/or full-text article. The sensitivity
of the search strategy was assessed by
screening the references of included
articles for additional publications. 
Data extraction and quality
assessment
The data from the included articles
were extracted to predefined Microsoft
Excel (Microsoft Inc., Redmond, WA,
USA) spreadsheets and studies were
assessed for validity by two researchers
independently. Collected data included
author, year of publication, study
design, sample size, definition of learn-
ing curve, pathologic data (CRM
involvement rate, CRM, TME quality,
distal margin, number of lymph nodes
harvested), and clinical data (operating
time, docking time, surgeon console
time, postoperative morbidity, anasto-
motic leak rate, SSI rate, length of hos-
pital stay, readmission rate). The quality
of each individual study was assessed
according to the Cochrane Handbook
for Systematic Reviews of Interventions
in terms of the following items: selec-
tion, performance, detection, attrition,
selective reporting, and other bias
risks.13 In cases where additional data
were needed, the senior authors of the
included studies were contacted and
asked for deidentified patient-level
data. 
Statistical analysis
The inverse variance method with
point estimates for standardized mean
differences and 95% confidence inter-
vals (MD (95%CI)) was used for contin-
uous var iables, whereas the
Mantel-Haenszel method with odds
ratios with 95% confidence intervals
(OR (95%CI)) was used for dichoto-
mous variables. In cases where continu-
ous variables were reported in median
and interquartile range, mean and stan-
dard deviation (SD) were estimated
using Hozo’s formula.17 Statistical het-
erogeneity among effect estimates was
assessed using Cochran Chi2 and I2, and
between-study variance was assessed
using the Tau2 statistic when I2 was 50%
or greater.18 A random-effects model of
meta-analysis was used to synthesize the
meta-data. The results of the meta-
analysis were illustrated on forest plots.
To assess the clinical significance of the
results, relative risk reduction (RRR),
absolute risk reduction (ARR) and
number needed to treat/harm (NNT)
with 95%CI were calculated. Funnel
plots of standard error, funnel plots of
precision by log OR, Egger’s test, and
Begg and Mazumdar rank correlation
tests were used to evaluate for publica-
tion bias. A p-value <0.05 was consid-
ered statistically significant. Statistical
analysis was performed using RevMan
(version 5.3; Nordic Cochrane Center,
Cochrane Collaboration, Copenhagen,
Denmark) and CMA Software (Version
3; Biostat, Englewood, NJ, USA). 
RESULTS
Literature search and study
selection
The details of the search strategy are
shown in Supplement 1 and the details
of study selection are presented in a
PRISMA flowchart (Figure 1). The six
searched databases revealed 234
records. Three additional articles were
found among the references of eligible
studies. Ten articles were included after
excluding duplicates, irrelevant articles,
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Figure 2. Number of included patients by country.
RESULTS
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and articles that did not report the out-
come of interest.   
Description of the included
studies
Ultimately, 10 studies were selected
from among 33 potentially eligible
studies19-28 totaling 907 patients (521
LC and 386 C). The characteristics of
the included studies are provided in
Table I. All 10 studies were cohort stud-
ies with an evidence level of 2b (8
prospective and 2 retrospective cohort
studies).19-28 All of the included studies
were published after 2012. Eligible arti-
cles that reported the outcomes of
patients operated on by the same sur-
geon or in the same institution with an
overlapping study span were exclud-
ed.29,30 Studies involving patients with
benign disease or colon cancers along-
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Supplement 2
Studies included in the quantitative analysis of different endpoints.
Pathologic endpoints
CRM involvement rate Foo 2016, Jimenez-Rodriguez 2013, Kim 2014, Kuo 2014, Park 2014, Sng 2013,
Yamaguchi 2015 
Number of lymph nodes harvested Foo 2016, Jimenez-Rodriguez 2013, Kim 2012, Kim 2014, Kuo 2014, Park 2014, 
Sng 2013, Yamaguchi 2015
Distal margin Foo 2016, Jimenez-Rodriguez 2013, Kim 2012, Kuo 2014, Park 2014, Sng 2013,
Yamaguchi 2015
Incomplete TME quality rate
Foo 2016, Jimenez-Rodriguez 2013, Kuo 2014, Yamaguchi 2015
CRM
Jimenez-Rodriguez 2013, Kuo 2014
Local recurrence rate
Jimenez-Rodriguez 2013, Kuo 2014, Park 2014, Sng 2013
CRM, circumferential resection margin; TME, total mesorectal excision.
Clinical endpoints: Intraoperative variables
Operating time
Foo 2016, Huang 2017, Jimenez-Rodriguez 2013, Kim 2012, Kim 2014, Kuo 2014,
Park 2014, Sng 2013, Yamaguchi 2015
Docking time Foo 2016, Jimenez-Rodriguez 2013, Park 2014, Yamaguchi 2015
Surgeon console time Foo 2016, Jimenez-Rodriguez 2013, Kim 2012, Park 2014, Yamaguchi 2015
Conversion rate Akmal 2012, Foo 2016, Jimenez-Rodriguez 2013, Kim 2012, Kim 2014, Kuo 2014,
Park 2014, Sng 2013, Yamaguchi 2015
Estimated blood loss Foo 2016, Huang 2017, Kuo 2014, Park 2014, Sng 2013, Yamaguchi 2015
Intraoperative complication rate Jimenez-Rodriguez 2013, Yamaguchi 2015
Clinical endpoints: Postoperative variables
Overall postoperative morbidity
Akmal 2012, Foo 2016, Huang 2017, Jimenez-Rodriguez 2013, Kim 2012, Kim 2014,
Kuo 2014, Park 2014, Sng 2013, Yamaguchi 2015
Anastomotic leak rate
Akmal 2012, Jimenez-Rodriguez 2013, Kim 2014, Kuo 2014, Park 2014, Sng 2013,
Yamaguchi 2015
Time to first flatus
Huang 2017, Jimenez-Rodriguez 2013, Kuo 2014, Park 2014, Sng 2013, 
Yamaguchi 2015
Time to soft diet resumption
Huang 2017, Jimenez-Rodriguez 2013, Kuo 2014, Park 2014, Sng 2013, 
Yamaguchi 2015
Length of hospital stay
Foo 2016, Huang 2017, Jimenez-Rodriguez 2013, Kuo 2014, Park 2014, Sng 2013,
Yamaguchi 2015
Readmission rate Foo 2016, Jimenez-Rodriguez 2013, Kuo 2014, Sng 2013, Yamaguchi 2015
- 145 -
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Table II
Quality assessment of included studies using NHLBI quality assessment tool for before-

















































































































































































NHLBI, National Heart, Lung, and Blood Institute; Y, yes; N, no; NR, not reported; NA, not applicable; Mod., moderate.
Supplement 3
NHLBI quality assessment tool for before-after (pre-post) studies with no control group:
criteria
Criteria Scale Items
Was the study question or objective clearly stated? 1
Were eligibility/selection criteria for the study population pre-specified and clearly described? 2
Were the participants in the study representative of those who would be eligible for the test/service/inter-
vention in the general or clinical population of interest?
3
Were all eligible participants that met the pre-specified entry criteria enrolled? 4
Was the sample size sufficiently large to provide confidence in the findings? 5
Was the test/service/intervention clearly described and delivered consistently across the study population? 6
Were the outcome measures pre-specified, clearly defined, valid, reliable, and assessed consistently
across all study participants?
7
Were the people assessing the outcomes blinded to the participants' exposures/interventions? 8
Was the loss to follow-up after baseline 20% or less? Were those lost to follow-up accounted for in the
analysis?
9
Did the statistical methods examine changes in outcome measures from before to after the intervention?
Were statistical tests done that provided p values for the pre-to-post changes?
10
Were outcome measures of interest taken multiple times before the intervention and multiple times after the
intervention (i.e., did they use an interrupted time-series design)?
11
If the intervention was conducted at a group level (e.g., a whole hospital, a community, etc.) did the statisti-
cal analysis take into account the use of individual-level data to determine effects at the group level?
*If this question is not applicable, total score is out of 11, not 12.
12
Y = Yes, N = No, NR = Not reported, CD = Cannot determine, NA = Not applicable, M = Moderate
Add scores for each criterion together and divide by 12.
Risk of bias rating (Low (75-100%), Moderate (25-75%), or High (0-25%))*
OVERALL SCORE:
- 146 -
side those with rectal cancer were also
excluded.31-34
Description of the study
populations and interventions
The patients in the 10 included stud-
ies were adults from 6 countries (USA,
Hong Kong, Taiwan, Spain, South
Korea, and Japan) (Figure 2). The
patients had similar baseline characteris-
tics. The studies stratified according to
the reported endpoints are shown in
Supplement 2. In seven of the 10
included studies, all procedures were
performed by the same sur-
geon.19,20,23,25-28 The procedures were
performed by two surgeons in one
study,24 and by three surgeons in anoth-
er study.22 In one study, all procedures
were performed by the same team, but
the number of surgeons was not report-
ed.21 The learning curve was found to
consist of 3 phases in six stud-
ies,20,22,24,26-28 2 phases in three stud-
ies,19,21,25 and 6 phases in one study.23
Anterior, low anterior, and ultralow
anterior resection of the rectum was
performed in nine of the 10 studies.19-
24,26-28 One study included only patients
with intersphincteric resection of the
rectum.25 Six studies included patients
with abdominoperineal resection of the
rectum19,20,22,23,27,28 and two studies
included patients with Hartmann’s pro-
cedure.20,23 The number of surgeons,
phases of the learning curve, and proce-
dures are summarized in Table I.
Quality assessment
All of the included studies provided
a 2b level of evidence according to the
Oxford Centre for Evidence Based
Medicine (CEBM) (Table I). The
National Heart, Lung, and Blood Insti-
tute (NHLBI) quality assessment tool
for before-after (pre-post) studies with
no control group was used. Criteria and
scoring principles of the NHLBI quality
assessment tool are provided in Supple-
ment 3. Quality assessment findings are
presented in Table II. Nine studies had a
low risk of bias,19,21-28 and one had a
moderate risk of bias.20 Figure 3 sum-
marizes the risk of bias and presents a
graph of the included studies. The
selection bias in pre-post design studies
was considered to be low when an
objective criterion was used to allocate
patients between the LC and C groups.
The objective criterion in our study was
a cumulative sum (CUSUM) analysis.
The risk of selection bias was low in six
studies,20,22,23,25,27,28 and was considered
to be high in the remaining four
studies.19,21,24,26 The risk of performance
and detection bias was high in almost all
of the studies. It is impractical to try to
prevent performance and detection bias
by blinding surgeons to the intervention
and assessment of the outcome. Attri-
tion, reporting, and other bias risks
were either low or unclear.
Meta-analysis 
CRM involvement rate
CRM involvement was defined as
CRM of ≤1 mm. The CRM involve-
ment rate was reported in 7 studies
(441 LC vs. 284 C).20,22,24-28 In a study
from Japan, a positive resection margin
was considered to be involved CRM.28
Statistical among-study heterogeneity
was low (I2=0%). The CRM involve-
ment rate was 2.9% (13/441) in LC vs.
4.6% (13/284) in C. This difference
was neither statistically nor clinically
significant (OR (95%CI) = 0.70 (0.30,
1.60); p=0.39; NNT (95%CI) = 62 (>
22.1 to benefit, > 78.8 to harm)) (Fig-
ure 4) (Table III). 
Number of lymph nodes
harvested
The number of lymph nodes harvest-
ed was reported in 8 studies (461 LC
vs. 326 C).20,22-28 Statistical among-
study heterogeneity was low (I2=3%).
No statistically significant difference
was found between LC and C (MD
(95%CI) = 0.04 (-1.30, 1.39);
p=0.95) (Figure 5a). 
Distal margin
The distal margin was reported in 7
studies (341 LC vs. 246 C).20,22,23,25-28
Statistical among-study heterogeneity
was low (I2=25%). No statistically sig-
nificant difference was found between
LC and C (MD (95%CI) = 0.03 (-0.32,
0.38); p=0.87) (Figure 5b).
Operating time, docking time,
and surgeon console time
Operating time was reported in 9
studies (481 LC vs. 346 C).20-28 Statisti-
cal among-study heterogeneity was high
(I2=89%; Tau2=1746.70). Operating
time was significantly longer in LC com-
pared to C (MD (95%CI) = 52.81
(23.49, 82.14); p=0.0004) (Figure 6a).
Docking time was reported in 4
studies (174 LC vs. 118 C).20,22,26,28
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was high (I2=96%; Tau2=14.63).
Docking time was significantly longer
in LC compared to C (MD (95%CI) =
7.83 (3.34, 12.32); p=0.0006) (Figure
6b).
Surgeon console time was reported
in 5 studies  (194 LC vs. 160
C).20,22,23,26,28 Statistical among-study
heterogeneity was high (I2=78%;
Tau2=343.42). Surgeon console time
was also significantly longer in LC
compared to C (MD (95%CI) =
29.58 (10.40, 48.77); p=0.003) (Fig-
ure 6c).
Conversion rate
The conversion rate was reported in 9
studies (501 LC vs. 366 C).19,20,22-28 Sta-
tistical among-study heterogeneity was
low (I2=41%). The conversion rate was
1.8% (9/501) in LC vs. 1.4% (5/366) in
C. This difference was neither statistical-
ly nor clinically significant (OR (95%CI)
= 1.65 (0.54, 5.10); p=0.38; NNT
(95%CI) = 233 (> 47.8 to benefit, >
81.1 to harm)) (Figure 6d) (Table III).
Estimated blood loss
Estimated blood loss (EBL) was report-
ed in 6 studies (320 LC vs. 202 C).20,21,25-28
Statistical among-study heterogeneity was
low (I2=0%). No statistically significant
difference in EBL was found between LC
and C (MD (95%CI) = 12.61 (-3.06,
28.29);p=0.11) (Figure 6e).
Postoperative complication rate
The postoperative complication rate
was reported in all 10 studies (521 LC
vs. 386 C).19-28 Statistical among-study
heterogeneity was low (I2=37%). The
postoperative complication rate was
19% (99/521) in LC vs. 24.6%
(5/366) in C. This difference was not
statistically significant (OR (95%CI) =
#1141-Yamaguchi    FINAL
Colorectal Surgery
SURGICAL TECHNOLOGY INTERNATIONAL Volume 34
Figure 4. Meta-analysis of LC vs. C: CRM involvement rate (primary endpoint).
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Figure 6 (cont). Secondary clinical endpoints of the meta-analysis of LC vs. C. (e) Estimated blood loss. (f) Postoperative complication rate. (g) Anastomotic leak
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Table III
Clinical significance of the statistical difference between LC and C
Endpoints RRR ARR (95%CI) NNT (95%CI)
CRM involvement rate














62 (> 22.1 to benefit, > 78.8 to harm)
54 (> 8.8 to benefit, > 13.2 to harm)
233 (> 47.8 to benefit, > 81.1 to harm)
18 (9.0, 669.7)
109 (> 10.7 to benefit, > 13.4 to harm)
RRR, relative risk reduction; ARR, absolute risk reduction; NNT, numbers needed to treat; 95%CI, 95% confidence interval;
CRM, circumferential resection margin; TME, total mesorectal excision.
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Supplement 4
Meta-analysis of LC vs. C: Circumferential resection margin (mm)
Supplement 5
Meta-analysis of LC vs. C: Incomplete TME quality rate
Supplement 6
Meta-analysis of LC vs. C: Local recurrence rate
Supplement 7
Meta-analysis of LC vs. C: Intraoperative complication rate
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0.71 (0.44, 1.14); p=0.16). However,
the difference was clinically significant
(NNT (95%CI) = 18 (9.0, 669.7))
(Figure 6f).
Anastomotic leak rate
The anastomotic leak rate was
reported in 7 studies (450 LC vs. 297
C).19,22,24-28 Statistical among-study het-
erogeneity was low (I2=36%). The
anastomotic leak rate was 6.2%
(28/450) in LC vs. 7.4% (22/297) in
C. This difference was not statistically
significant (OR (95%CI) = 0.82 (0.35,
1.94); p=0.65) (Figure 6g).
Time to first flatus
Time to first flatus was reported in 6
studies (316 LC vs. 210 C).21,22,25-28 Sta-
tistical among-study heterogeneity was
high (I2=86%; Tau2=0.28). Time to first
flatus was not significantly different
between LC and C (MD (95%CI) = 0.10
(-0.40, 0.59); p=0.70) (Figure 6h).
Time to soft diet resumption
Time to soft diet resumption was
reported in 6 studies (316 LC vs. 210
C).21,22,25-28 Statistical among-study het-
erogeneity was low (I2=40%). Time to
soft diet resumption was not significantly
different between LC and C (MD
(95%CI) = 0.32 (-0.04, 0.69); p=0.08)
(Figure 6i).
Length of hospital stay
Length of stay (LOS) was reported
in 7 studies (341 LC vs. 224 C) 20-22,25-
28. Statistical among-study heterogene-
ity was low (I2=0%). LOS was not
significantly different between LC and
C (MD (95%CI) = 0.35 (-0.29, 0.99);
p=0.29) (Figure 6j).
Readmission rate
The readmission rate was reported
in 5 studies (243 LC vs. 152
C).20,22,25,27,28 Statistical among-study
heterogeneity was moderate (I2=47%;
Tau2=0.65). The readmission rate was
22.6% (55/243) in LC vs. 21.7%
(33/152) in C. This difference was nei-
ther statistically nor clinically significant
(OR (95%CI) = 1.66 (0.56, 4.88);
p=0.36; NNT (95%CI) = 109 (> 10.7
to benefit, > 13.4 to harm)) (Figure
6k) (Table III).
Other endpoints
The results of the meta-analysis for
additional endpoints (incomplete TME
quality rate, circumferential resection
margin, local recurrence rate, and intra-
operative complication rate) are pre-
sented in Supplements 4, 5, 6, and 7.
Clinical significance
Relative r isk reduction (RRR),
absolute risk reduction (ARR), and
number needed to treat (NNT) for pri-
mary and some secondary endpoints are
shown in Table III. The only endpoint
with clinical significance was the post-
operative complication rate.  
Sensitivity analysis and
publication bias
A sensitivity analysis of the included
studies was performed by excluding
studies with the highest risk of bias.
This did not affect the findings. Publica-
tion bias was evaluated by a visual
assessment of symmetry in the funnel
plot (Figure 7), the funnel plot of preci-
sion by log OR, Egger’s test (t= 1.72;
p= 0.16), and Begg and Mazumdar rank
correlation tests (Tau= -0.4; p= 0.26)
(Supplement 8). No publication bias
was found.
DISCUSSION
This meta-analysis was designed to
evaluate whether the learning curve in
robotic surgery for rectal cancer has any
impact on histopathologic outcomes.  
Interpretation of the results 
The lack of a significant difference
in CRM involvement rates between LC
and C suggests that the six degrees of
freedom of the RSS instruments
(rather than the surgeon’s competence)
are the limiting factors that determine
CRM involvement rates. Furthermore,
the surgeon’s learning curve did not
affect either the number of lymph
nodes harvested or the distal margin.
Additional pathologic endpoints such
as CRM, incomplete TME quality
rates, and local recurrence rates (Sup-
plements 4, 5, and 6) did not allow us
to draw robust conclusions due to the
insufficient number of studies (two
studies) reporting the outcome or high
heterogeneity.  
The findings of significantly
decreased total operating time, docking
time, and surgeon console time were as
expected. However, there was high het-
erogeneity across the studies, since only
6 studies used a CUSUM analy-
sis.20,22,23,25,27,28 The findings of this
meta-analysis allow us to draw reliable
conclusions because the learning curve
did not affect conversion rates or EBL.
Since only two studies reported intra-
operative complication rates,22,28, we
could not draw any clinically sound
conclusions. 
There were no statistically significant
differences in postoperative complica-
tion rates between LC and C (19% vs.
25%, respectively). However, NNT
analysis showed that experience with 18
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Figure 7. Meta-analysis of LC vs. C: Funnel plot (primary endpoint).
DISCUSSION
- 153 -
cases during LC could prevent one post-
operative complication during C. A
higher postoperative complication rate
could be explained by increased case
complexity and surgeon confidence. LC
did not affect anastomotic leak or read-
mission rates, time to soft diet resump-
tion, or LOS. Although the time to first
flatus was similar among the studies,
high heterogeneity did not allow us to
draw robust and clinically sound conclu-
sions.  
The finding that the tumor distance
from the anal verge was a risk factor
for CRM involvement was expected.
However, while male gender and high
BMI were also expected to be risk fac-
tors, they did not yield significant
results. 
Existing evidence
Robotic surgery for rectal cancer is
controversial for several reasons,
including (but not limited to) operating
time, learning curve, and cost. This
meta-analysis is in line with previous
studies suggesting that learning is asso-
ciated with a prolonged operating time.
Nonetheless, a recent study found that
an operating time over 300 minutes was
not a risk factor for postoperative com-
plications.11 Aside from operating time,
this meta-analysis shows that learning
has no detr imental impact on
histopathologic outcomes. In fact, this
meta-analysis supports previous evi-
dence12 suggesting that CRM involve-
ment is not affected by learning.
Histopathologic outcomes and recur-
rence rates (rather than only cost)32
should play the key roles in the era of
value-based care. 
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Evaluation of publication bias risk: funnel plot of precision, results of Egger’s test, 
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This meta-analysis was based on a
literature search in several databases
and an evaluation of metrics of clinical
significance (relative and absolute risk
reduction, numbers needed to
treat/harm). 
However, it has several limitations.
All of the eligible studies were observa-
tional studies that included only a small
number of patients. Nonetheless, the
pre-post design of the studies with the
allocation of patients based on a
CUSUM analysis decreased the overall
risk of bias. There was some hetero-
geneity in study interventions: 6 studies
included patients with abdominoper-
ineal resection of the rectum, and 2
studies included patients with Hart-
mann’s procedure. An overall lack of
details regarding key outcomes was a
common limitation of most studies,
which precludes us from drawing con-
clusions about the root causes of some
important outcomes, such as CRM and
TME quality. Insufficient information
about the previous experience of par-
ticipating surgeons with laparoscopic




The evidence provided in this meta-
analysis is sufficient to constitute level
1a evidence that the learning curve for
robotic surgery for rectal cancer has no
impact on histopathologic outcomes.
However, the limitations of this meta-
analysis, e.g., lack of evidence regarding
TME quality, should be taken into
account. Further studies on the impact
of the learning curve for robotic rectal
cancer surgery on histopathologic out-
comes are required. However, any fur-
ther research should use a CUSUM
analysis to identify phases of the learn-
ing curve and include more details on
histopathologic outcomes, such as CRM
and TME quality. 
CONCLUSIONS
This meta-analysis found that learn-
ing had no detrimental impact on CRM
involvement rates compared to the sur-
geon’s competence in robotic surgery
for rectal cancer. More detailed report-
ing on other histopathologic metrics is
necessary to improve our understanding
of the role of the learning curve in
robotic rectal cancer surgery.
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